MESINA, Flordeluna, Z.

MESINA, Flordeluna, Z.

Assistant Professor Flordeluna Zapata Mesina, MD, MSc, FPCP, FPCHTM, contributes significantly to the field of medicine as a faculty member in the Department of Pharmacology and Department of Medicine at UST Faculty of Medicine & Surgery. With key administrative roles, Dr. Mesina serves as the Chief Program Officer for Continuing Medical Education (CME) at USTFMS, showcasing her commitment to professional development. Additionally, she holds the position of vice president at the Philippine College of Hematology and Transfusion Medicine (PCHTM) and Chief Program Officer at the USTFMS Office of Continuing Medical Education. Dr. Mesina’s scholarly focus extends to Hematology, Myeloproliferative Neoplasms, and Clinical Epidemiology. Her academic journey includes a Master’s of Science in Clinical Epidemiology from the University of the Philippines-Manila, a Fellowship in Clinical Hematology at UST Hospital, and a Residency in Internal Medicine at UST Hospital. Acknowledging her excellence, Dr. Mesina received the Most Outstanding Fellow award at UST Hospital in 2015 and was recognized as the Most Outstanding Resident by the Philippine College of Physicians (PCP) in 2012. She maintains professional affiliations as a Fellow in the Philippine College of Hematology and Transfusion Medicine and a Life Member of the Philippine College of Physicians. Dr. Mesina is an active consultant at UST Hospital and Cardinal Santos Medical Center

Updates

Asst. Prof. Flordeluna Z. Mesina, MD, MSc, FPCP, FPCHTM

Department of Medicine | Faculty of Medicine and Surgery

fzmesina@ust.edu.ph

Academic Qualifications

Research Highlights

Research Interests

Academic Qualifications

Degrees

  • Masters of  Science in Clinical Epidemiology, University of the Philippines – Manila, Philippines
  • Doctor of Medicine, University of Santo Tomas – Manila, Philippines,
  • Bachelor of Science in Public Health, University of the Philippines – Manila, Philippines

Eligibility

  • Professional Regulation Commission Physician Licensure Examination

Postgraduate Studies

  • Fellowship in Clinical Hematology, UST Hospital
  • Residency in Internal Medicine, UST Hospital 
  • Postgraduate Internship, UST Hospital

 

Research Highlights

  • Dr. Mesina is a clinical researcher in multiple areas in hematology including blood cancers with special interest on myeloproliferative neoplasms, multiple myeloma and AML/MDS.
  • She was commissioned by the hematology society to make research projects and position papers during the pandemic on convalescent plasma and covid-19 vaccines.
  • She continue to expand her research portfolio through international and local collaborations.

Research Interests

  • Hematology
  • Myeloproliferative Neoplasm
  • Clinical Epidemiology

Courses Handled

Major Recognitions

Professional Activities

Courses Handled

  • Medicine 2 (3rd year Medical Students)
  • Medicine 3 – Clerkship (4th year Medical Students) 
  • Pharmacology
  • MDI-2

    

Major Recognitions

  • Most Outstanding Fellow, UST Hospital, 2015
  • Most Outstanding Resident, Philippine College of Physicians PCP 2012

Professional Activities

ACADEMIC APPOINTMENT

  • Assistant Professor 1, Department of Pharmacology, UST Faculty of Medicine and Surgery

ADMINISTRATIVE APPOINTMENTS/POSITONS

  • Chief Program Officer, CME, UST Faculty of Medicine and Surgery
  • Vice-president, Philippine College of Hematology and Transfusion Medicine
  • PCHTM Chief Program Officer, USTFMS Office of Continuing Medical Education

PROFESSIONAL AFFILIATIONS

  • Fellow, Philippine College of  Hematology and Transfusion Medicine
  • Life Member, Philippine College of Physicians

HOSPITAL AFFILIATIONS

  • UST Hospital 
  • Cardinal Santos Medical Center

Selected Publications

Selected Publications

  • Flordeluna Z. Mesina, MD; Frances Alexandra D. Sapinoso, MD; Joy Ann V. de Castro, MD, Preeti Prerna M. Vaswani, MD; Charles Eryll S. Sy, MD; Rizza Ann A. Oquendo; Mark Ryann A. Lirasan Hematologic Adverse Events After COVID-19 Vaccination in the Philippines: A National Database Study (HAE Vax study), December 2022 Vaccine. 2023;41(23):3550-3555. doi:10.1016/j.vaccine.2023.04.066
  • Flordeluna Z. Mesina. Severe relapsed autoimmune hemolytic anemia after booster with mRNA-1273 COVID-19 vaccine, May 2022. Hematology, Transfusion and Cell Therapy. 2022; https://doi.org/10.1016/j.htct.2022.05.001
  • Mesina, MD FZ, Dumagay TE, Alejandria MM, Castillo-Carandang NT. Burden of Symptoms and Symptom Experience of Filipino Patients with Myeloproliferative Neoplasm: A Qualitative Phenomenological Approach. Acta Med Philipp. 2023, November 2016
  • Joy Ann de Castro, Flordeluna Mesina, Priscilla Caguioa. Profile and Treatment Outcomes of Filipino Multiple Myeloma Patients Managed at a Tertiary Institution: A Six-Year Retrospective Study, Clinical Lymphoma Myeloma and Leukemia, Volume 19, Issue 10, Supplement,2019,Page e227, ISSN 2152-2650, https://doi.org/10.1016/j.clml.2019.09.377.
  • Michael Lee, Charles Eryll Sy, Flordeluna Mesina et al. Acute leukemia diagnosis through AI-enhanced ATR-FTIR spectroscopy of peripheral blood smear, 29 November 2023, PREPRINT (Version 1) available at Research Square [https://doi.org/10.21203/rs.3.rs-3660767/v1]